Ultrasound Sample Entropy Imaging: A New Approach for Evaluating Hepatic Steatosis and Fibrosis

IEEE J Transl Eng Health Med. 2021 Nov 2:9:1800612. doi: 10.1109/JTEHM.2021.3124937. eCollection 2021.

Abstract

Objective: Hepatic steatosis causes nonalcoholic fatty liver disease and may progress to fibrosis. Ultrasound is the first-line approach to examining hepatic steatosis. Fatty droplets in the liver parenchyma alter ultrasound radiofrequency (RF) signal statistical properties. This study proposes using sample entropy, a measure of irregularity in time-series data determined by the dimension [Formula: see text] and tolerance [Formula: see text], for ultrasound parametric imaging of hepatic steatosis and fibrosis. Methods: Liver donors and patients were enrolled, and their hepatic fat fraction (HFF) ([Formula: see text]), steatosis grade ([Formula: see text]), and fibrosis score ([Formula: see text]) were measured to verify the results of sample entropy imaging using sliding-window processing of ultrasound RF data. Results: The sample entropy calculated using [Formula: see text] 4 and [Formula: see text] was highly correlated with the HFF when a small window with a side length of one pulse was used. The areas under the receiver operating characteristic curve for detecting hepatic steatosis that was [Formula: see text]mild, [Formula: see text]moderate, and [Formula: see text]severe were 0.86, 0.90, and 0.88, respectively, and the area was 0.87 for detecting liver fibrosis in individuals with significant steatosis. Discussion/Conclusions: Ultrasound sample entropy imaging enables the identification of time-series patterns in RF signals received from the liver. The algorithmic scheme proposed in this study is compatible with general ultrasound pulse-echo systems, allowing clinical fibrosis risk evaluations of individuals with developing hepatic steatosis.

Keywords: Fatty liver; hepatic steatosis; sample entropy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Entropy
  • Humans
  • Liver Cirrhosis / diagnostic imaging
  • Non-alcoholic Fatty Liver Disease* / diagnostic imaging
  • Ultrasonography

Grants and funding

This work was supported in part by the Ministry of Science and Technology in Taiwan under Grant MOST 109-2223-E-182-001-MY3, in part by Chang Gung Memorial Hospital, Linkou, Taiwan, under Grant CMRPD1K0421 and Grant CMRPD1H0381, and in part by the National Natural Science Foundation of China under Grant 11804013.